BSE Sensex is likely to reclaim its former high of and Nifty 50 may rise to ahead of the Union Budget 2022, said Sanjiv Bhasin, Director, IIFL Securities, in an interview with Surbhi Jain of Financial Express Online. Bhasin also expects Nifty to rally 22 per cent from current situations to a new each- time high of 22000 by April 2022. He sees an downside of over 7 per cent in BSE Sensex, and expects it to hit 65000 by early May this time on advanced earnings. Also, amid COVID supporter shots and antiviral medicines developments, Bhasin believes that pharma stocks may deliver good quarter results and suggests investors to stay incompletely invested in pharmaceutical stocks. Then are the edited extracts.
1.BSE Sensex is likely to reclaim its former high of and Nifty 50 may rise to ahead of the Union Budget 2022, said Sanjiv Bhasin, Director, IIFL Securities, in an interview with Surbhi Jain of Financial Express Online. Bhasin also expects Nifty to rally 22 per cent from current situations to a new each- time high of 22000 by April 2022. He sees an downside of over 7 per cent in BSE Sensex, and expects it to hit 65000 by early May this time on advanced earnings. Also, amid COVID supporter shots and antiviral medicines developments, Bhasin believes that pharma stocks may deliver good quarter results and suggests investors to stay incompletely invested in pharmaceutical stocks. Then are the edited extracts.
2. What do you suggest retail investors should buy and vend? Could you name a many stocks that may gain in the near term?
Keep your Draft going as timing the requests will be insolvable in a bull request. Anybody who has tried to time entry in the last two times, has lost the stylish rally in over 5 times. Sectors similar as banks, construction and reality are going to lead, followed by IT and pharma. Stocks of ICICI Bank, IDFC First Bank, L&T, Godrej Properties, and HCL Technologies, may gain in the near- term.
3. With so important developments on COVID-19 vaccine, supporter shots and antiviral medicines, is it time to hold pharma stocks?
. Stay incompletely invested in pharma stocks as the stylish part of earnings may be behind us. The top stock picks are Cipla, Sun Pharmaceutical Diligence, andDr. Reddy’s Laboratories with Lupin a dark steed.
4. What are your light and fat sectors? Which stocks do you suppose have implicit to offer decent returns in near- term?
The light sector would be consumer masses and the fat would be infrastructure spending stocks. Dark Steed stocks are NBCC (India), NLC India, and Union Bank of India.
5. Do you believe the IPO rush of 2021 will continue in 2022 as well? Which bones should investors look for?
Yes, the IPO rush may continue this time as well as PE backing is now reaping the benefits of new age technology in digital and fintech. LIC India will set the ball rolling for the PSU side, investors must enjoy this.
6. What will be the crucial motorists of equity requests in 2022?
The crucial motorists of equity requests in 2022 will be growth, earnings, and the power of the retail Draft, which has hit Rs crore per month and has eased the finished influence of foreign investors.
